⏰ Last chance! Join Premium for $20/month before it increases to $49/month.

Liminatus Pharma, Inc. Class A Common Stock

$3.71
+0.00 (+0.00%)

Volume:

20.365K ($75.56K)

Market Capitalization:

$4.98M

Live Price

Live Volume

Chart Volume 0
Volume 0
5 sec

Liminatus Pharma Class A Market Segments

Overnight

*No Trades in Segment

After Hours

*No Trades in Segment

Regular Trading Hours

+0.01(+0.27%)
Open$3.70
Close$3.71
Low$3.65
Low Change-0.05 (-1.35%)
High$3.82
High Change+0.12 (+3.24%)
Range$0.17
Volume20.265K
Dollar Volume$75.18K

Premarket

+0.00(+0.00%)
Open$3.80
Close$3.80
Low$3.80
Low Change0.00 (0.00%)
High$3.80
High Change+0.00 (+0.00%)
Range$0.00
Volume100
Dollar Volume$380.00

After Hours Yesterday

+0.00(+0.00%)
Open$3.70
Close$3.70
Low$3.70
Low Change0.00 (0.00%)
High$3.70
High Change+0.00 (+0.00%)
Range$0.00
Volume372
Dollar Volume$1.38K

Regular Trading Hours Yesterday

+0.07(+1.92%)
Open$3.64
Close$3.71
Low$3.61
Low Change-0.03 (-0.82%)
High$3.91
High Change+0.27 (+7.42%)
Range$0.30
Volume16.588K
Dollar Volume$61.54K

Premarket Yesterday

+0.00(+0.00%)
Open$3.88
Close$3.88
Low$3.88
Low Change0.00 (0.00%)
High$3.95
High Change+0.07 (+1.72%)
Range$0.07
Volume1.754K
Dollar Volume$6.81K

Liminatus Pharma Class A Top Trades

Liminatus Pharma Class A's top trade so far today returned +3.24%, while the top short trade returned -3.95%.

Liminatus Pharma Class A Moving Averages

5 Day Moving Average (SMA5)$3.85
10 Day Moving Average (SMA10)$4.25
20 Day Moving Average (SMA20)$2.19
50 Day Moving Average (SMA50)$0.94
100 Day Moving Average (SMA100)$0.56
200 Day Moving Average (SMA200)$0.58

Liminatus Pharma Class A Statistics

Average Volume (30 Days)
P/E Ratio (Current)
EPS (Current)
Dividend Yield
Free Cash Flow
Cash Ratio
Current Ratio
Quick Ratio
Debt to Equity
Enterprise Value
EV to EBITDA
EV to Sales
Price to Book
Price to Cash Flow
Price to Free Cash Flow
Price to Sales
Return on Assets
Return on Equity

Liminatus Pharma Class A Stock Splits

There has been 1 stock split for Liminatus Pharma Class A (LIMN). The reverse stock split occured on August 21, 2026 and reduced the outstanding shares at a ratio of 50:1.

DateTypeRatio
Aug 21, 2026Reverse50:1

Liminatus Pharma Class A Dividends

There have been no dividends for Liminatus Pharma Class A (LIMN).